Orientador: Fernando Leite Hoffmann / Banca: Elisa Yoko Hirooka / Banca: Crispin Humberto Garcia Cruz / Resumo: No Brasil, estima-se que, de cada cinco refeições, uma não é efetuada em casa, sendo a salada de maionese um dos alimentos comumente consumidos. Este produto alimentício é basicamente constituído por vegetais cozidos posteriormente adicionados de maionese. Portanto, além da microbiota presente nos vegetais, a falta de higiene dos manipuladores durante o seu preparo, bem como as condições de armazenamento do produto, faz com que os microrganismos possam vir a ocasionar deteriorações no alimento ou intoxicações alimentares nos consumidores. Neste trabalho as Boas Práticas de Fabricação (BPF) foram verificadas em 10 estabelecimentos produtores de saladas de maionese aplicando um check - list que se constituiu de 123 itens de verificação baseado na legislação vigente no país (Resolução da Diretoria Colegiada - RDC nº. 216 de 2004) e análise da qualidade microbiológica perante 57 amostras destas saladas comercializadas na cidade de São José do Rio Preto - SP. As análises microbiológicas foram realizadas em 2 etapas: a primeira em 30 amostras no período de junho, agosto e outubro de 2006, e a segunda etapa no período de fevereiro, abril e junho de 2007, após a aplicação do check - list e orientações para o correto manuseio desse alimento. Foram realizadas as seguintes análises: contagem de bolores e leveduras, Staphylococcus aureus, Número Mais Provável (NMP) de coliformes totais, termotolerantes, pesquisa de Escherichia coli e de Salmonella spp., bem como procedeu-se a identificação das leveduras isoladas e o teste de resistência frente a diferentes concentrações do conservante sorbato de potássio. De acordo com o check - list aplicado para verificação das BPF, 70,0% dos estabelecimentos apresentaram não conformidades superiores a 25,0%, sendo classificados como insatisfatórios para produção de alimentos...(Resumo completo clicar acesso eletrônico abaixo) / Abstract: The aim of this work was to verify the Good Manufacturing Practices (GMP) and the microbiologic quality of the salads added of mayonnaise marketed in São José do Rio Preto - SP, through the following analyses: check - list application, based on the legislation in force in the country, which classified the levels of suitability presented by the producers, counting of mould and yeast, Staphylococcus aureus, determining the Most Probable Number of total and heat resistant coliforms, Escherichia coli and Salmonella spp research, and proceeded to identification isolated yeast and resistance test to different concentrations of potassium sorbate conserver. According to the check - list applied to GMP verification, 70,0% of the establishments showed no conformities above 25,0%, being classified as unsatisfactory for food production. The obtained result for mould and yeast counting varied from 1,9 x 103 to 6,0 x 106.. The biggest number of mayonnaise salad contamination was caused by Staphylococcus aureus with variations of < 100 a 1,8 x 107 UFC/g. For The Most Probable Number determination of total and heat resistant coliforms a variation of < 3 a > 1100 NMP/g was verified. Escherichia coli was found in all samples positive for heat resistantt coliforms. Salmonella spp. was not found. From the ten establishments 4 (40%) improved the salads quality with mayonnaise added and 1 (10%) stopped this food production after inspection and the technicians of Sanitary Survellance guidance. In relation to the isolated yeasts, Debaryomyces hansenii var. fabryii species was the most frequent, in 19 cultures (76,0%) followed by Cryptococcus laurentii with 4 (16%), Arxula adeninovorans with 1 (4,0%). The species Arxula adeninovorans and Candida edax were not sensitive to potassium sorbate conserver. In relation to...(Complete abstract click electronic access below) / Mestre

Este projeto tem por objetivo desenvolver um checklist de boas práticas de fabricação (BPF) adaptado ao público das agroindústrias familiares de pequeno porte (AFPP) produtoras de embutidos, de modo que sirva como ferramenta de auxílio na recomendação das AFPP ao SUSAF-RS (Sistema Estadual Unificado de Sanidade Agroindustrial Familiar e de Pequeno Porte do RS). Foram visitadas 20 agroindústrias situadas nas regionais da Emater de Lajeado e Soledade, onde foi aplicado o checklist de BPF original (BRASIL, 2002) bem como o checklist adaptado desenvolvido. As agroindústrias foram classificadas em G1, G2 e G3 conforme o percentual de conformidade (C). A proposta do checklist adaptado se justificou uma vez que o instrumento proposto apresentou resultado de agroindústrias classificadas com G1 (>75% C) significativamente superior em relação à classificação obtida das mesmas agroindústrias submetidas ao checklist original. O checklist adaptado mostrou que a maioria das agroindústrias foi classificada como pertencente ao G2 com média de conformidade de 59,2%. Somente 4 agroindústrias, além da unidade onde foi aplicado o piloto, obtiveram mais de 75% de C sendo classificadas como G1. Todas estas estão registradas em Serviços de Inspeção Municipais já aderidos ao SUSAF, e uma apresenta registro no Serviço de Inspeção Estadual. Além destas, 8 agroindústrias foram classificadas no G2 e 7 foram classificadas no G3. As principais não conformidades (NC) identificadas nas classificações G2 e G3 foram relacionadas à gestão documental (SG5) e falhas no quesito higiênico-sanitário (SG2), sendo que 5 das 8 agroindústrias classificadas como G2 apresentaram C superior a 65%. Nestes casos, a gestão documental foi o principal gargalo para o não atingimento dos 75% de C preconizado. Ressalta-se que das 7 agroindústrias classificadas como G3, 4 apresentaram índices preocupantes no quesito sanitário (SG2) com C inferior a 25%. O trabalho evidenciou que as AFPPs localizadas em municípios cujos SIMs não estão estruturados, atrelado à presença de RTs pouco atuantes, ocasionam baixo índice de BPF, pois carecem de informações técnicas e capacitação para implantação das mesmas. Percebeu-se que a realidade da AFPP é distinta à da indústria de larga escala. Por isso, parece justo que os dois segmentos sejam avaliados de forma diferenciada, justificando o propósito do projeto. / This project deals with the adaptation of a Good Manufacturing Practices (GMP) checklist for application in small farm agroindustry producing sausages. The objective will be to enable the proposed checklist to serve as an aid tool in the recommendation of this profile of agroindustries to SUSAF-RS (Unified State System of Agroindustrial Health and Small Porte of RS). Twenty agroindustries distributed in the regional municipalities of Emater de Lajeado and Soledade were visited, where the original BPF checklist (BRASIL, 2002) was applied as well as the adapted checklist. The agroindustries were classified in G1, G2 and G3 according to the percentage of compliance (C). The proposal of the checklist adapted to measure BPF in the scope of the small farm agroindustry was justified, since the proposed instrument presented a result of agroindustries classified with G1 (> 75% C) significantly higher than the classification obtained from the same agroindustries submitted to the original checklist. The adapted checklist showed that most agro-industries were classified as belonging to G2 with a mean of 59.2% compliance. Only 4 agroindustries, besides the unit where the pilot was applied, obtained more than 75% of C being classified as G1, therefore, with GMP implanted. All of these are registered in Municipal Inspection Services that have already joined the SUSAF. In addition, 8 agro-industries were classified in G2 and 7 were classified in G3. The main non-conformities (NC) identified in the G2 and G3 classifications were related to document management (SG5) and sanitary-sanitary (SG2) failures, with 5 of the 8 agro-industries classified in G2 presenting C above 65%. cases, document management was the main bottleneck for not achieving the 75% of C recommended. It is noteworthy that of the 7 agroindustries classified as G3, 4 presented worrying rates in the sanitary (SG2) with C less than 25%. The work can show that the small farm agroindustry s located in municipalities whose Inspcetion Local Service are not fully structured, coupled with the presence of weakly active professional suporting, present a low GMP index, since they lack technical information and capacity to implement the Manual of GMPs and SSOPs. It was perceived that the reality of small farm agroindustry is distinct from that of large-scale industry. Therefore, it seems fair that these two segments are evaluated in a differentiated way, justifying the purpose of the project.

CoordenaÃÃo de AperfeiÃoamento de Pessoal de NÃvel Superior / Estudamos o efeito do citrato de sildenafil (ViagraÂ), vasodilatador largamente utilizado na terapÃutica da disfunÃÃo erÃtil, sobre o comportamento motor do trato gastrintestinal (TGI) de ratos Wistar. Para tanto, utilizamos 175 animais machos, pesando entre 200 a 350g, distribuÃdos nos quatro seguintes grupos de estudo: efeitos do citrato de sildenafil sobre o i) esvaziamento gÃstrico (EG) e os trÃnsitos gastrintestinal (GI) e ii) intestinal de lÃquido em ratos acordados; iii) a complacÃncia gÃstrica de ratos anestesiados e iv) a contratilidade de tiras isoladas do duodeno de ratos ex vivo. i) Avaliamos, em 64 ratos acordados sob jejum e livre acesso à Ãgua por 24h, o efeito da injeÃÃo (0,2mL; e.v.) de sildenafil (4mg/Kg) ou veÃculo (HCl 0,01N) sobre o EG e o trÃnsito GI de lÃquido, bem como sobre a pressÃo arterial (PA). Mediante gavagem, 1,5mL da refeiÃÃo-teste (vermelho de fenol - 0,5mg/mL em glicose a 5%) foi injetada no estÃmago. Depois de 10, 20 ou 30min, sacrificamos os animais e, apÃs laparotomia, obstruÃmos o piloro, o cÃrdia e o Ãleo terminal. Removemos e dividimos o TGI em: estÃmago e segmentos consecutivos do intestino delgado (40% iniciais; 30% mediais e 30% terminais). ApÃs o processamento destas porÃÃes viscerais, determinamos as absorbÃncias das amostras a 560nm. A retenÃÃo fracional de vermelho fenol em cada segmento permitiu o cÃlculo do EG e trÃnsito GI. Em um grupo separado de animais, a PA foi monitorada continuamente por meio de um sistema digital de aquisiÃÃo de dados durante 20min antes e 30min apÃs o tratamento com sildenafil ou diluente. Comparado ao grupo controle, houve aumento significativo da retenÃÃo gÃstrica (44,2Â2,0 vs 53,2Â2,1; 25,4Â1,3 vs 37,3Â1,6; 20,9Â2,5 vs 32,5Â2,9%) nos animais tratados com sildenafil e sacrificados aos 10, 20, ou 30min, respectivamente, bem como retarde significativo no trÃnsito GI. Embora o sildenafil tenha provocado hipotensÃo, a PA retoma nÃveis basais logo apÃs 10min. O prÃ-tratamento com omeprazol (bloqueador da secreÃÃo Ãcida estomacal) nÃo modificou o efeito do sildenafil sobre os valores de retenÃÃo gÃstrica e intestinal nem nos nÃveis de PA. ii) Noutros animais (n=44), sob jejum de 24h e dotados previamente (3d) de uma cÃnula crÃnica no bulbo duodenal, estudamos o efeito do sildenafil sobre a progressÃo ao longo do intestino delgado de uma refeiÃÃo teste (10MBq de TecnÃcio ligado a fitato e diluÃdo em 1mL de salina 0,9%). Decorridos 20, 30 ou 40min da injeÃÃo (0,2mL e.v.) de sildenafil (4mg/Kg) ou diluente (HCL 0,01N), sacrificamos os animais e, apÃs laparotomia e remoÃÃo do TGI, dividimo-o em: estÃmago, cinco segmentos congruentes e consecutivos de intestino delgado e o intestino grosso. A contagem da radiatividade foi determinada num colimador de gama-cÃmara. O sildenafil promoveu retarde (p<0,05) do TI, indicado pelos retardes dos centros geomÃtricos da refeiÃÃo de 2,8&#61617; 0,2 vs 3,3&#61617; 0,1; 3,0&#61617; 0,2 vs 3,7&#61617; 0,1 e 3,4&#61617; 0,1 vs 4,2&#61617; 0,2 em relaÃÃo ao grupo controle, aos 20, 30 ou 40min. iii) Os estudos de complacÃncia gÃstrica foram conduzidos em 39 ratos anestesiados, sob jejum de 24h. As variaÃÃes do volume gÃstrico (VG), foram medidas por pletismografia, enquanto a PA foi monitorada continuamente por um sistema digital de aquisiÃÃo de dados. Em relaÃÃo aos valores basais (2,91Â0,19mL) o sildenafil (3mg/Kg â e.v.) aumentou (p<0,05) o VG apÃs 10, 20 e 30min (3,08Â0,18; 3,10Â0,17 e 3,09Â0,17mL). A PA basal (105,8Â2,28mmHg) caiu significativamente com o sildenafil (59,8Â3,2; 64,8Â3,7 e 59,3Â4,6mmHg) enquanto o diluente (HCl 0,01N) nÃo modificou seja o VG ou a PA. O prÃ-tratamento mediante esplancnotomia ou injeÃÃo e.v. com azul de metileno (3mg/Kg-bloqueador da guanilato ciclase), L-NNA (3mg/Kg-bloqueador da NO sintetase) ou propranolol (2mg/Kg-Ã-bloqueador) preveniram o aumento do VG pelo sildenafil; jà o pÃs-tratamento com nitroprussiato de sÃdio (1mg/Kg - e.v.) o ampliou significativamente. iv) Avaliamos ainda o efeito do sildenafil sobre a contratilidade de tiras isoladas do duodeno de ratos ex vivo (n=28), sacrificados por deslocamento cervical. Tiras dissecadas do duodeno foram suspensas longitudinalmente em cuba de vidro (10mL), plena de soluÃÃo de Tyrode (37oC e pH 7,4), e submetidas a uma tensÃo inicial de 1g. ApÃs 1h de estabilizaÃÃo, a contratilidade espontÃnea ou induzida das tiras foi registrada continuamente por um sistema digital de aquisiÃÃo de dados. O sildenafil em doses crescentes e cumulativas (0,1 a 300Âmol/L) relaxou (EC50 de 9,6Âmol/L) o duodeno, mais atà que o zaprinaste ou a papaverina (bloqueadores de FDEs) (EC50 91,6 e 78,5Âmol/L, nesta ordem). Observamos ademais que o sildenafil inibiu as contraÃÃes induzidas por acetilcolina ou carbacol (IC50 26,7 e 16,2Âmol/L, respectivamente). Jà o prÃ-tratamento com azul de metileno, ODQ (bloqueador da guanilato ciclase) ou L-NAME (bloquedor da NO sintetase), mas nÃo o D-NAME (isÃmero inativo da NO sintetase) preveniram o efeito do sildenafil. O efeito mio-relaxante do sildenafil foi ampliado pela L-arginina (substrato do NO sintetase) ou nitroprussiato de sÃdio (doador de NO). O prÃ-tratamento com forskolina (estimulador da adenilato ciclase) tambÃm aumentou o efeito mio-relaxante do sildenafil. Em resumo, observamos que o sildenafil diminui a motilidade gastrintestinal, retardando o EG, os trÃnsitos GI e intestinal de lÃquido em ratos acordados; aumenta a complacÃncia gÃstrica em ratos anestesiados alÃm de apresentar efeitos antiespasmÃdico e mio-relaxante sobre tiras isoladas de duodeno de ratos ex vivo; por estimulaÃÃo do sistema nervoso simpÃtico e tendo como provÃvel mecanismo de aÃÃo ao nÃvel do miÃcito gastrintestinal a via do NO/GMP cÃclico. / We evaluated the effect of sildenafil citrate (ViagraÂ) a vasodilator largely used for the treatment of male erectile dysfunction, on the gastrointestinal motility in rats. Experiments were performed on 175 male, Wistar rats, weighing 200-350g. Four groups of study were done: the sildenafil effects on the: i) Gastric emptying (GE) and gastrointestinal (GI) transit and ii) Intestinal transit (IT) of liquid in awake rats; iii) Gastric compliance in anesthetized rats and iv) Contractility of rat duodenal isolated strips. i) In 64 rats fasted for 24h with previous vascular access (right jugular vein and left carotid artery), we studied the effect of an i.v. injection (0.2mL) of sildenafil (4mg/Kg) or vehicle (0.01N HCl) on GE and GI transit of a liquid meal, as well as on arterial pressure (AP) in a separated group of rats. Animals were gavage-fed with 1.5mL of a test meal (0.5mg/mL of phenol red in 5% glucose). After 10, 20 or 30min, animals were sacrificed and submitted to a laparotomy to obstruct the pylorus, cardia and terminal ileus. The gut was removed and then divided into: stomach and consecutive three small intestine segments (40% proximal; 30% medial and 30% terminal). After processing these segments, the dye retention was determined at 560nm. The percentage of dye retention in each segment permitted to evaluate GE and GI transit. Arterial pressure was continuously monitored by a digital acquisition system during 20min before and 30min after sildenafil injection. We observed a significant increase of gastric retention in sildenafil treated rats at 10, 20, or 30min after the test meal (44,2Â2,0 vs 53,2Â2,1; 25,4Â1,3 vs 37,3Â1,6; 20,9Â2,5 vs 32,5Â2,9%, respectively), as well as a significant GI transit delay. Despite of sildenafil inducing hypotension, AP returned to basal levels 10min afterwards. Acid gastic secretion blocking pre-treatment with omeprazol did not modify the sildenafil effect on gastric retention, GI transit or AP. ii) In another group we evaluated the sildenafil (4mg/Kg) or diluente (0.01N HCl, 0.2mL) effects on the IT in awake rats, fasted for 24h. Animals were studied 3d after the insertion of a silastic cannula (0.6cm ID) into the duodenal bulb. We evaluated the progression of a radioactive liquid test meal fed (10MBq of 99mTc â 1mL of saline 0,9%) administered through the inserted cannula into the small intestine. After 20, 30 or 40min, animals were sacrificed by anesthetic overdose. After laparotomy, we removed and divided the gut in: stomach, five congruent and consecutive segments of the small intestine and the large intestine. Radioactivity counting was obtained in a gamma-chamber collimator. Sildenafil promoted an IT delay (p<0.05), indicated by shifting the center of mass to the proximal portions of the TGI (2.8Â0.2 vs 3.3Â0.1; 3.0Â0.2 vs 3.7Â0.1 and 3.4Â0.1 vs 4.2Â0.2) in relation to control group. iii) Gastric compliance study was performed on 39 anesthetized rats after 24h of fasting. Gastric volume (GV) variations were measured by plethysmography while AP was continuously monitored. We have also observed that GV increased (p<0.05) after sildenafil treatment (3mg/Kg - e.v) (3.08Â0.18; 3.10Â0.17 and 3.09Â0.17mL vs 2.91Â0.19mL) at 10, 20 and 30min after drug administation, respectively. Basal AP (105.8Â2.28mmHg) dropped by the sildenafil injection (59.8Â3.2; 64.8Â3.7 and 59.3Â4.6mmHg-p<0.05) while vehicule (0.01N HCl) did not change either GV or AP. After splanchnotomy or pre-treatments (e.v.) with methylene blue (3mg/Kg-guanilate cyclase blocker), L-NNA (3mg/Kg - NO synthase blocker) or propranolol (2mg/Kg - Ã-blocker) prevented GV increase due to sildenafil; while post-treatment with sodium nitroprusside (1mg/Kg - NO donor) raised it. iv) The in vitro contractility studies were performed on isolated duodenal strips obtained from rats (n=28) killed by cervical dislocation. Duodenal strips were suspended longitudinally in a glass chamber (10mL), filled with Tyrode solution (37oC and pH 7.4). After 1h of stabilization under 1g of initial tension, the spontaneous or induced contractility were continuously recorded by a digital acquisition system. Increasing and cummulative doses of sildenafil (0.1 to 300Âmol/L) relaxed (9.6Âmol/L of EC50) the duodenal strips. This effect was more intense than those displayed by zaprinast or papaverine (PDEs blockers) (91.6 and 78.5Âmol/L of EC50, in this order). Sildenafil showed significant antispasmodic and myorelaxant effects on the duodenal contractions induced by acetylcholine or carbamylcholine (IC50 26.7 and 16.2Âmol/L, respectively). Pre-treatment with methylene blue, ODQ (guanilato cyclase blocker) or L-NAME (NO synthase blocker) also prevented these sildenafil effects, but D-NAME (an inactive substrate for NO synthase) did not. Myorelaxant sildenafil effect was reverted by L-arginine (substrate for NO synthase) and contrarily it was largely increased by sodium nitroprusside. Forskolin adenylate cyclase activation pre-treatment also increased the myorelaxant effect of sildenafil. In summary, we have observed that sildenafil slowed down the gastrointestinal motility, delaying GE, GI and intestinal transits of a liquid meal in awake rats; Gastric compliance was also increased in anesthetized rats treated with sildenafil. Sildenafil also exhibited both antispasmodic and myorelaxant effects on isolated strips of duodenum of ex vivo rats. Besides central or peripheral sympathetic nervous system activation, sildenafil possibly acts at the gastrointestinal myocite level by activating the NO/GMPc system.

A vida moderna impôs novos hábitos alimentares para a população e a maior participação da mulher no mercado de trabalho estimula a alimentação fora do lar. Buscando diversificar suas atividades comerciais e atender esse mercado crescente, muitos supermercados estão implantando uma seção de rotisseria, no qual são produzidos e comercializados alimentos prontos para o consumo. Em muitos supermercados, essa seção é improvisada, sem atender as Boas Práticas de Manipulação, podendo representar um perigo à saúde dos consumidores. Os objetivos deste trabalho foram fazer um estudo crítico do problema da qualidade e inocuidade alimentar na seção de rotisseria de supermercados e apresentar um exemplo de um estabelecimento na cidade de São Paulo no qual uma área foi adaptada para uma rotisseria. Nessa rotisseria improvisada, aplicou-se a Lista de Verificação das Boas Práticas de Manipulação em Estabelecimentos da Área de Alimentos (LVBPMEA) da Prefeitura Municipal de São Paulo e alguns produtos colocados à venda foram submetidos à análises microbiológicas, para verificar se atendiam os padrões microbiológicos legais vigentes (Resolução RDC12 item 22, ANVISA). O estudo indicou que rotisserias em supermercados representam um novo e promissor mercado, mas os supermercadistas necessitam compreender que esse setor necessita de atenção diferenciada, por envolver produtos de alto risco para a saúde da população. Essa necessidade foi comprovada pelos resultados obtidos no supermercado estudado, onde numerosos pontos da LVBPMEA e da RDC12 não foram atendidos. Este exemplo pode refletir a realidade de muitos supermercados no Brasil. / Modern life style is imposing new eating habits and the increased participation of women in the work market estimulates having meals outside the home. Envisaging a new and promising market, supermarkets are adapting areas for preparation and selling of meals (rotisseries). In many supermakets, these improvised areas do not follow the recommended Good Manufacturing Practices, endangering consumers health. The present study aimed to address the issue concerned to quality and safety of meals prepared in these rotisseries, and present an example of a supermarket in the city of São Paulo in which an area was transformed in a rotisserie for cooking and selling ready-to-eat foods. The Good Manufacturing Practices Verification List, of the Mayority of São Paulo city, was applied to this improvised rotisserie, and some samples of ready-to-eat foods were submitted to microbiological testing in order to evaluate their compliance with the legal Brazilian microbiological standards (Resolução RDC12 item 22, ANVISA). The review indicated that rotisseries in supermarkets are a growing market in Brazil, but the managers need to understand that this sector needs special attention because the foods for sale may be risky for the consumers health. The need for special attention was strengthened by the results in the studied supermarket, where many points and products were not in accordance with the GMP Verification list and the legal Brazilian microbiological standards. This example may reflect the reality in many supermarkets in Brazil.

Resources Events Agents (REA) ontology is a profound business modeling ontology that was developed to define the architecture of accounting information systems. Nevertheless, REA did not manage to get the same attention as other business modeling ontologies. One reason of such abandon is the absence of a meaningful visual notation for the ontology, which has resulted in an abstruse ontology to non-academic audience. Another reason for this abandon is the fact that REA does not have a standard formal representation. This has resulted in a humble amount of researches which have focused on defining meta-models of the ontology while neglecting the wider purpose of REA-based information systems development. Consequently, the ontology was deviated away from its original purpose, and rather used in business schools. To solve the aforementioned issues, this research presents a Model Driven Development (MDD) technique in the form of a REA-based Domain Specific Visual Language (DSVL) that is implemented within a modeling and code generation editor. This effort was taken in order to answer the question of “How would a REA-DSVL based tool make the REA ontology implementable in the domain of information systems development?” In order to answer the research question, a design science methodology (DSRM) was implemented as the structure of this research. The DSRM was chosen because this research aims to develop three main artifacts. These are; a meta-model of REA, a visual notation of REA, and a REA-DSVL-based modeling and code generation tool. The first phase of the DSRM was to identify the problems which were mentioned earlier, followed by the requirements identification phase which drew the outline of the; meta-model, the visual notation, and the tool. After that, the development phase was conducted in order to develop the aforementioned artifacts. The editor was then demonstrated using a case study of a local company in Stockholm-Sweden. Finally, the resulted artifacts were evaluated based on the collected requirements and the results from the case study. Based on the analyses of the artifacts and the case study, this research was concluded with the result that a REA-based DSVL tool can help in boosting the planning and analysis phases of the software development lifecycle (SDLC). This is achieved by automating some of the conventional software planning and design tasks, which would lead to more accurate systems’ designs; thus, minimizing the time of the planning and design phases. And it can be achieved by abstracting the direct logic of REA through providing functionalities that help users from different backgrounds (academic and professional) to embrace a business modeling editor rather than an ontology; thus, attracting a wider users base for implementing REA.

The second messenger cyclic diguanylate monophosphate (c-di-GMP) has been proven to be a central regulator for physiological and metabolic processes including biofilm formation and sessile to motile transitioning (1,2). The synthesis and degradation of c-di-GMP are regulated by GGDEF- respectively EAL-domain proteins. Recently, c-di-GMP has been discovered in the Gram-positive Streptococcus genus including Streptococcus gallolyticus, which showed to have diguanylate cyclase activity (3). Characterisation of the c-di-GMP network in other Streptococcus is of relevance. Hence, the aim of this project was the assessment of the GGDEF- and EAL domains from the animal pathogenic Streptococcus uberis and Streptococcus henryi. In vivo recombination cloning was used for the analysis of the GGDEF, EAL and GGDEF-EAL domain proteins from S. uberis and S. henryi. The cloning was unsuccessful for most of the domain proteins, except, for EAL 2 of S. uberis. However, analysis of the sequencing results for the cloned EAL 2 presented mutations. Further studies testing alternative cloning methods should be applied. Research regarding probiotic streptococci is also of interest. Therefore, isolation of Streptococcus salivarius from human oral samples using Streptococcus Selection Agar was conducted. Isolation of S. salivarius from human saliva and tongue samples was successful using Streptococcus Selection Agar. Other Streptococcus spp., Lactobacillus, Staphylococcus, and additional bacterial species were also isolated.

A rising problem in agriculture is the increase of antibiotic-resistant Salmonella cases associated with chicken eggs, which transmit infection to humans. To counter this, new approaches to combat Salmonella in chickens and desiccated on eggshells are vital in the prevention of human foodborne illness. Disrupting signaling pathways with naturally occurring compounds provides a potential novel avenue for prevention of Salmonella infections, as this would disrupt sensing of these environments and inhibit subsequent optimal gene expression. Starting with signals identified in previous studies, salicylic acid was found to inhibit Salmonella desiccation survival on both eggshells and plastic. To expand upon this, a desiccation inhibition screen of 285 signals resulted in 9 additional potential desiccation inhibitors, including deoxyribose and guanine. By using natural signals to disrupt bacterial communication pathways, novel therapeutics that serve as viable antibacterial alternatives could be developed to prevent Salmonella contamination at a major source.

CoordenaÃÃo de AperfeiÃoamento de Pessoal de NÃvel Superior / We evaluated the effect of sildenafil citrate (ViagraÂ) a vasodilator largely used for the treatment of male erectile dysfunction, on the gastrointestinal motility in rats. Experiments were performed on 175 male, Wistar rats, weighing 200-350g. Four groups of study were done: the sildenafil effects on the: i) Gastric emptying (GE) and gastrointestinal (GI) transit and ii) Intestinal transit (IT) of liquid in awake rats; iii) Gastric compliance in anesthetized rats and iv) Contractility of rat duodenal isolated strips. i) In 64 rats fasted for 24h with previous vascular access (right jugular vein and left carotid artery), we studied the effect of an i.v. injection (0.2mL) of sildenafil (4mg/Kg) or vehicle (0.01N HCl) on GE and GI transit of a liquid meal, as well as on arterial pressure (AP) in a separated group of rats. Animals were gavage-fed with 1.5mL of a test meal (0.5mg/mL of phenol red in 5% glucose). After 10, 20 or 30min, animals were sacrificed and submitted to a laparotomy to obstruct the pylorus, cardia and terminal ileus. The gut was removed and then divided into: stomach and consecutive three small intestine segments (40% proximal; 30% medial and 30% terminal). After processing these segments, the dye retention was determined at 560nm. The percentage of dye retention in each segment permitted to evaluate GE and GI transit. Arterial pressure was continuously monitored by a digital acquisition system during 20min before and 30min after sildenafil injection. We observed a significant increase of gastric retention in sildenafil treated rats at 10, 20, or 30min after the test meal (44,2Â2,0 vs 53,2Â2,1; 25,4Â1,3 vs 37,3Â1,6; 20,9Â2,5 vs 32,5Â2,9%, respectively), as well as a significant GI transit delay. Despite of sildenafil inducing hypotension, AP returned to basal levels 10min afterwards. Acid gastic secretion blocking pre-treatment with omeprazol did not modify the sildenafil effect on gastric retention, GI transit or AP. ii) In another group we evaluated the sildenafil (4mg/Kg) or diluente (0.01N HCl, 0.2mL) effects on the IT in awake rats, fasted for 24h. Animals were studied 3d after the insertion of a silastic cannula (0.6cm ID) into the duodenal bulb. We evaluated the progression of a radioactive liquid test meal fed (10MBq of 99mTc â 1mL of saline 0,9%) administered through the inserted cannula into the small intestine. After 20, 30 or 40min, animals were sacrificed by anesthetic overdose. After laparotomy, we removed and divided the gut in: stomach, five congruent and consecutive segments of the small intestine and the large intestine. Radioactivity counting was obtained in a gamma-chamber collimator. Sildenafil promoted an IT delay (p<0.05), indicated by shifting the center of mass to the proximal portions of the TGI (2.8Â0.2 vs 3.3Â0.1; 3.0Â0.2 vs 3.7Â0.1 and 3.4Â0.1 vs 4.2Â0.2) in relation to control group. iii) Gastric compliance study was performed on 39 anesthetized rats after 24h of fasting. Gastric volume (GV) variations were measured by plethysmography while AP was continuously monitored. We have also observed that GV increased (p<0.05) after sildenafil treatment (3mg/Kg - e.v) (3.08Â0.18; 3.10Â0.17 and 3.09Â0.17mL vs 2.91Â0.19mL) at 10, 20 and 30min after drug administation, respectively. Basal AP (105.8Â2.28mmHg) dropped by the sildenafil injection (59.8Â3.2; 64.8Â3.7 and 59.3Â4.6mmHg-p<0.05) while vehicule (0.01N HCl) did not change either GV or AP. After splanchnotomy or pre-treatments (e.v.) with methylene blue (3mg/Kg-guanilate cyclase blocker), L-NNA (3mg/Kg - NO synthase blocker) or propranolol (2mg/Kg - Ã-blocker) prevented GV increase due to sildenafil; while post-treatment with sodium nitroprusside (1mg/Kg - NO donor) raised it. iv) The in vitro contractility studies were performed on isolated duodenal strips obtained from rats (n=28) killed by cervical dislocation. Duodenal strips were suspended longitudinally in a glass chamber (10mL), filled with Tyrode solution (37oC and pH 7.4). After 1h of stabilization under 1g of initial tension, the spontaneous or induced contractility were continuously recorded by a digital acquisition system. Increasing and cummulative doses of sildenafil (0.1 to 300Âmol/L) relaxed (9.6Âmol/L of EC50) the duodenal strips. This effect was more intense than those displayed by zaprinast or papaverine (PDEs blockers) (91.6 and 78.5Âmol/L of EC50, in this order). Sildenafil showed significant antispasmodic and myorelaxant effects on the duodenal contractions induced by acetylcholine or carbamylcholine (IC50 26.7 and 16.2Âmol/L, respectively). Pre-treatment with methylene blue, ODQ (guanilato cyclase blocker) or L-NAME (NO synthase blocker) also prevented these sildenafil effects, but D-NAME (an inactive substrate for NO synthase) did not. Myorelaxant sildenafil effect was reverted by L-arginine (substrate for NO synthase) and contrarily it was largely increased by sodium nitroprusside. Forskolin adenylate cyclase activation pre-treatment also increased the myorelaxant effect of sildenafil. In summary, we have observed that sildenafil slowed down the gastrointestinal motility, delaying GE, GI and intestinal transits of a liquid meal in awake rats; Gastric compliance was also increased in anesthetized rats treated with sildenafil. Sildenafil also exhibited both antispasmodic and myorelaxant effects on isolated strips of duodenum of ex vivo rats. Besides central or peripheral sympathetic nervous system activation, sildenafil possibly acts at the gastrointestinal myocite level by activating the NO/GMPc system. / Estudamos o efeito do citrato de sildenafil (ViagraÂ), vasodilatador largamente utilizado na terapÃutica da disfunÃÃo erÃtil, sobre o comportamento motor do trato gastrintestinal (TGI) de ratos Wistar. Para tanto, utilizamos 175 animais machos, pesando entre 200 a 350g, distribuÃdos nos quatro seguintes grupos de estudo: efeitos do citrato de sildenafil sobre o i) esvaziamento gÃstrico (EG) e os trÃnsitos gastrintestinal (GI) e ii) intestinal de lÃquido em ratos acordados; iii) a complacÃncia gÃstrica de ratos anestesiados e iv) a contratilidade de tiras isoladas do duodeno de ratos ex vivo. i) Avaliamos, em 64 ratos acordados sob jejum e livre acesso à Ãgua por 24h, o efeito da injeÃÃo (0,2mL; e.v.) de sildenafil (4mg/Kg) ou veÃculo (HCl 0,01N) sobre o EG e o trÃnsito GI de lÃquido, bem como sobre a pressÃo arterial (PA). Mediante gavagem, 1,5mL da refeiÃÃo-teste (vermelho de fenol - 0,5mg/mL em glicose a 5%) foi injetada no estÃmago. Depois de 10, 20 ou 30min, sacrificamos os animais e, apÃs laparotomia, obstruÃmos o piloro, o cÃrdia e o Ãleo terminal. Removemos e dividimos o TGI em: estÃmago e segmentos consecutivos do intestino delgado (40% iniciais; 30% mediais e 30% terminais). ApÃs o processamento destas porÃÃes viscerais, determinamos as absorbÃncias das amostras a 560nm. A retenÃÃo fracional de vermelho fenol em cada segmento permitiu o cÃlculo do EG e trÃnsito GI. Em um grupo separado de animais, a PA foi monitorada continuamente por meio de um sistema digital de aquisiÃÃo de dados durante 20min antes e 30min apÃs o tratamento com sildenafil ou diluente. Comparado ao grupo controle, houve aumento significativo da retenÃÃo gÃstrica (44,2Â2,0 vs 53,2Â2,1; 25,4Â1,3 vs 37,3Â1,6; 20,9Â2,5 vs 32,5Â2,9%) nos animais tratados com sildenafil e sacrificados aos 10, 20, ou 30min, respectivamente, bem como retarde significativo no trÃnsito GI. Embora o sildenafil tenha provocado hipotensÃo, a PA retoma nÃveis basais logo apÃs 10min. O prÃ-tratamento com omeprazol (bloqueador da secreÃÃo Ãcida estomacal) nÃo modificou o efeito do sildenafil sobre os valores de retenÃÃo gÃstrica e intestinal nem nos nÃveis de PA. ii) Noutros animais (n=44), sob jejum de 24h e dotados previamente (3d) de uma cÃnula crÃnica no bulbo duodenal, estudamos o efeito do sildenafil sobre a progressÃo ao longo do intestino delgado de uma refeiÃÃo teste (10MBq de TecnÃcio ligado a fitato e diluÃdo em 1mL de salina 0,9%). Decorridos 20, 30 ou 40min da injeÃÃo (0,2mL e.v.) de sildenafil (4mg/Kg) ou diluente (HCL 0,01N), sacrificamos os animais e, apÃs laparotomia e remoÃÃo do TGI, dividimo-o em: estÃmago, cinco segmentos congruentes e consecutivos de intestino delgado e o intestino grosso. A contagem da radiatividade foi determinada num colimador de gama-cÃmara. O sildenafil promoveu retarde (p<0,05) do TI, indicado pelos retardes dos centros geomÃtricos da refeiÃÃo de 2,8 0,2 vs 3,3 0,1; 3,0 0,2 vs 3,7 0,1 e 3,4 0,1 vs 4,2 0,2 em relaÃÃo ao grupo controle, aos 20, 30 ou 40min. iii) Os estudos de complacÃncia gÃstrica foram conduzidos em 39 ratos anestesiados, sob jejum de 24h. As variaÃÃes do volume gÃstrico (VG), foram medidas por pletismografia, enquanto a PA foi monitorada continuamente por um sistema digital de aquisiÃÃo de dados. Em relaÃÃo aos valores basais (2,91Â0,19mL) o sildenafil (3mg/Kg â e.v.) aumentou (p<0,05) o VG apÃs 10, 20 e 30min (3,08Â0,18; 3,10Â0,17 e 3,09Â0,17mL). A PA basal (105,8Â2,28mmHg) caiu significativamente com o sildenafil (59,8Â3,2; 64,8Â3,7 e 59,3Â4,6mmHg) enquanto o diluente (HCl 0,01N) nÃo modificou seja o VG ou a PA. O prÃ-tratamento mediante esplancnotomia ou injeÃÃo e.v. com azul de metileno (3mg/Kg-bloqueador da guanilato ciclase), L-NNA (3mg/Kg-bloqueador da NO sintetase) ou propranolol (2mg/Kg-Ã-bloqueador) preveniram o aumento do VG pelo sildenafil; jà o pÃs-tratamento com nitroprussiato de sÃdio (1mg/Kg - e.v.) o ampliou significativamente. iv) Avaliamos ainda o efeito do sildenafil sobre a contratilidade de tiras isoladas do duodeno de ratos ex vivo (n=28), sacrificados por deslocamento cervical. Tiras dissecadas do duodeno foram suspensas longitudinalmente em cuba de vidro (10mL), plena de soluÃÃo de Tyrode (37oC e pH 7,4), e submetidas a uma tensÃo inicial de 1g. ApÃs 1h de estabilizaÃÃo, a contratilidade espontÃnea ou induzida das tiras foi registrada continuamente por um sistema digital de aquisiÃÃo de dados. O sildenafil em doses crescentes e cumulativas (0,1 a 300Âmol/L) relaxou (EC50 de 9,6Âmol/L) o duodeno, mais atà que o zaprinaste ou a papaverina (bloqueadores de FDEs) (EC50 91,6 e 78,5Âmol/L, nesta ordem). Observamos ademais que o sildenafil inibiu as contraÃÃes induzidas por acetilcolina ou carbacol (IC50 26,7 e 16,2Âmol/L, respectivamente). Jà o prÃ-tratamento com azul de metileno, ODQ (bloqueador da guanilato ciclase) ou L-NAME (bloquedor da NO sintetase), mas nÃo o D-NAME (isÃmero inativo da NO sintetase) preveniram o efeito do sildenafil. O efeito mio-relaxante do sildenafil foi ampliado pela L-arginina (substrato do NO sintetase) ou nitroprussiato de sÃdio (doador de NO). O prÃ-tratamento com forskolina (estimulador da adenilato ciclase) tambÃm aumentou o efeito mio-relaxante do sildenafil. Em resumo, observamos que o sildenafil diminui a motilidade gastrintestinal, retardando o EG, os trÃnsitos GI e intestinal de lÃquido em ratos acordados; aumenta a complacÃncia gÃstrica em ratos anestesiados alÃm de apresentar efeitos antiespasmÃdico e mio-relaxante sobre tiras isoladas de duodeno de ratos ex vivo; por estimulaÃÃo do sistema nervoso simpÃtico e tendo como provÃvel mecanismo de aÃÃo ao nÃvel do miÃcito gastrintestinal a via do NO/GMP cÃclico.

The mammalian spinal cord contains the neuronal circuitry necessary to generate rhythmic locomotor activity in the absence of inputs from the higher brain centre or sensory system. This circuitry is regulated by local neuromodulatory inputs, which can adjust the strength and timing of locomotor output. The free radical gas nitric oxide has been shown to act as an important neuromodulator of spinal circuits, which control locomotion in other vertebrate models such as the tadpole and lamprey. Despite this, the involvement of the NO-mediated soluble guanylate cyclase/cyclic guanosine monophosphate secondary messenger-signalling pathway (NO/sGC/cGMP) in mammalian locomotion has largely been under-investigated. The NADPH diaphorase histochemical reaction was used to identify sources of NO in the lumbar spinal cord. The largest population NADPH diaphorase reactive neurons were located in the dorsal horn, followed by the laminae of the ventral horn, particularly around the central canal (lamina X) and lamina VII. NADPH diaphorase reactive neurons were found along a rostrocaudal gradient between lumbar segments L1 to L5. These results show that that discrete neuronal sources of NO are present in the developing mouse spinal cord, and that these cells increase in number during the developmental period postnatal day P1 – P12. NADPH diaphorase was subsequently used to identify NADPH diaphorase reactive neurons at P12 in the mouse model of ALS using the SODG93A transgenic mouse. Physiological recordings of ventral root output were made to assess the contribution of NO to the regulation induced rhythmic fictive locomotion in the in vitro isolated spinal cord preparation. Exogenous NO inhibits central pattern generator (CPG) output while facilitating and inhibiting motor neuron output at low and high concentrations respectively. Removal of endogenous NO increases CPG output while decreasing motor neuron output and these effects are mediated by cGMP. These data suggest that an endogenous tone of NO is involved in the regulation of fictive locomotion and that this involves the NO/sGC/cGMP pathway. Intracellular recordings from presumed motor neurons and a heterogeneous, unidentified sample of interneurons shows that NO modulates the intrinsic properties of spinal neurons. These data suggest that the net effect of NO appears to be a reduction in motor neuron excitability.

A produção de kits para diagnóstico in vitro deve ser feita seguindo-se a legislação vigente de Boas Práticas de Fabricação e Controle (BPF). O objetivo deste trabalho foi elaborar um procedimento para desenvolvimento, produção e validação de um produto para diagnóstico in vitro, de acordo com a legislação vigente. Adotamos como modelo um kit imunoenzimático para Doença de Chagas. Dentro dos requisitos de BPF, a validação é uma etapa importante, pois tem por objetivos, dentre outros: auxiliar no estabelecimento de procedimentos de produção e controle de qualidade, avaliar desvios e dimensionar possíveis erros, avaliar o desempenho quanto à utilidade médica dos resultados obtidos e estabelecer condições ideais de uso. No estabelecimento dos requisitos para validação devem-se considerar as características do método utilizado, a utilidade clínica e diagnóstica dos resultados e as condições de uso do kit. Os parâmetros para validação devem ser definidos considerando a finalidade do uso do produto. Os resultados obtidos em três lotes pilotos demonstraram que o kit pode ser utilizado tanto com soro como com plasma, as amostras podem ser congeladas e descongeladas antes do uso por até 5 ciclos, o índice de concordância com kit comercial é de 0,9 (ótimo) e o kit mantém-se estável por pelo menos 7 dias à 37ºC, o que neste trabalho foi equivalente a pelo menos um ano na sua condição ideal de armazenamento de 2 a 8ºC. Além disso, o kit apresentou 100% de sensibilidade, 99% de especificidade, com coeficiente de variação 15,2% tanto na repetitividade como na reprodutibilidade de amostras positivas. Quanto à análise de interferentes, amostras hemolisadas e a presença de fator reumatóide podem interferir nos resultados e anticorpos anti-Leishmania na amostra podem dar reação cruzada. Conclui-se que o procedimento elaborado e o kit desenvolvido e validado atenderam aos requisitos pré-estabelecidos, de acordo com as regras de BPF vigentes. / The production of an in vitro diagnostic kit should be done following current Good Manufacturing Practices (GMP). The objective of this work was to establish a procedure for the development, production and validation of an in vitro diagnostic product in accordance with current regulations governing Medical Devices. An enzyme-linked immunoassay kit for Chagas\' disease was used as a model. Validation is a very important step contained within GMP requirements. Validation provides documented evidence that processes and product batches are consistent, it aids in the establishment of production and quality control procedures, evaluate deviations and identify possible mistakes, evaluate the performance and medical usefulness of the product based on the obtained results, and establish ideal conditions of use and storage. In order to establish validation requirements for product development, it is necessary to consider the characteristics of the assay method, the clinical and diagnostic usefulness of the results and the conditions of use of the kit. The parameters for validation should be defined considering the purpose of the use of the product. In the case of this Chagas assay, results obtained in three pilot lots demonstrated that the kit could be used with both serum and plasma, samples could be frozen and thawed before use for up to 5 cycles. The agreement index when compared with a commercially licensed kit is 0,9 (optimum correlation). The kit remained stable for at least 7 days at 37ºC, which is equivalent to at least one year stability in its ideal storage condition of 2 to 8ºC. The kit presented 100% sensitivity and 99% specificity, with variation coefficient of 15,2% for both repeatability and reproducibility of the positive samples. Interference analysis indicated that: hemolyzed samples and the presence of reumathoid factor could interfere with test results. Antibodies anti-Leishmania in the test sample can cross react with T. cruzi proteins. In conclusion: the established procedure for development and validation of chagas kit, and the actual developed and validated kit are in accordance with pre-established current GMP requirements.